金新农(002548) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥1,069,619,354.61, a decrease of 14.97% compared to ¥1,257,861,446.80 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥148,556,592.76, a decline of 869.14% from a profit of ¥19,314,569.43 in the previous year[5] - The company reported a net loss of ¥187,475,293.17 for Q1 2022, compared to a net profit of ¥47,306,532.90 in the same period last year, indicating a significant decline in profitability[32] - Operating profit for the quarter was -¥167,809,397.05, a stark contrast to the operating profit of ¥59,804,215.97 in Q1 2021[32] - Total revenue from sales of goods and services was ¥1,120,481,097.32, slightly down from ¥1,140,635,346.97 in the previous year[34] - Total comprehensive loss for the quarter was ¥187,475,293.17, compared to a comprehensive income of ¥16,467,812.90 in Q1 2021[33] - The company reported a basic earnings per share of -¥0.17, compared to ¥0.03 in the previous year[33] Cash Flow and Assets - The net cash flow from operating activities was ¥100,913,103.54, an increase of 139.19% compared to a negative cash flow of ¥257,500,350.11 in the same period last year[5] - The company's cash and cash equivalents at the end of the period were CNY 844,398,270.33, an increase of 7.67% from CNY 784,414,719.21 at the beginning of the year[27] - The cash and cash equivalents at the end of the period stood at ¥756,213,683.52, compared to ¥850,573,419.62 at the end of Q1 2021[36] - The company incurred research and development expenses of ¥15,766,093.01, down from ¥23,008,529.90 in Q1 2021, reflecting a 31.5% decrease[32] - The company’s investment activities resulted in a net cash outflow of -¥31,345,919.11, compared to -¥432,217,299.09 in Q1 2021, indicating improved cash management[36] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,780,936,797.72, down 1.25% from ¥5,854,217,111.26 at the end of the previous year[6] - Total liabilities increased to CNY 3,974,772,782.63, compared to CNY 3,849,012,479.57 at the start of the year[29] - The company reported a net loss of CNY 910,324,782.84 in retained earnings, worsening from a loss of CNY 761,768,190.08 at the beginning of the year[29] - The company’s non-current liabilities decreased to CNY 1,068,096,506.22 from CNY 1,281,298,513.64 at the beginning of the year[29] Shareholder Information - Total number of common shareholders at the end of the reporting period is 51,120[17] - Guangzhou Jinnong Industry Investment Partnership holds 36.29% of shares, totaling 250,699,507 shares[17] - The top ten shareholders include several funds managed by Industrial and Commercial Bank of China, with varying shareholdings from 0.78% to 36.29%[18] - The company has 128,499,507 shares under limited sale conditions held by its largest shareholder[17] Strategic Plans - The company plans to raise up to RMB 700 million through a non-public offering of A-shares, with a maximum of 126 million shares to be issued[19] - The company intends to sell 100% equity of its subsidiary Wuhan Tianzhong Agricultural Technology Development Co., Ltd. for a listing price of RMB 138.98 million[22] - The company has completed the transfer of 51% equity of its subsidiary Wuhan Huayang Animal Medicine Co., Ltd. for RMB 153 million[23] - The company plans to acquire 49% equity of its subsidiary Fujian Yichun Agricultural Development Co., Ltd. for RMB 271.1 million, making it a wholly-owned subsidiary[23] - The company is focusing on optimizing resource allocation and enhancing its core development strategy in pig farming[22] Expenses - Management expenses decreased by 60.84%, mainly due to organizational streamlining and reduced personnel costs[14] - Research and development expenses decreased by 31.48%, reflecting a reduction in R&D investment during the reporting period[14] - The company’s financial expenses included interest expenses of ¥28,719,946.72, slightly down from ¥30,360,326.07 in the previous year[32]